Domperidone nanocrystals with boosted oral bioavailability: fabrication, evaluation and molecular insight into the polymer-domperidone nanocrystal interaction

The aim of this study was to employ experimental and molecular modelling approaches to use molecular level interactions to rationalise the selection of suitable polymers for use in the production of stable domperidone (DOMP) nanocrystals with enhanced bioavailability. A low-energy antisolvent precip...

Full description

Bibliographic Details
Published in:Drug Delivery and Translational Research
Main Author: Ndlovu S.T.; Ullah N.; Khan S.; Ramharack P.; Soliman M.; de Matas M.; Shahid M.; Sohail M.; Imran M.; Shah S.W.A.; Hussain Z.
Format: Article
Language:English
Published: Springer Verlag 2019
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85059829630&doi=10.1007%2fs13346-018-00596-w&partnerID=40&md5=87bd281b490efeb6588739abc50ef57c
id 2-s2.0-85059829630
spelling 2-s2.0-85059829630
Ndlovu S.T.; Ullah N.; Khan S.; Ramharack P.; Soliman M.; de Matas M.; Shahid M.; Sohail M.; Imran M.; Shah S.W.A.; Hussain Z.
Domperidone nanocrystals with boosted oral bioavailability: fabrication, evaluation and molecular insight into the polymer-domperidone nanocrystal interaction
2019
Drug Delivery and Translational Research
9
1
10.1007/s13346-018-00596-w
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85059829630&doi=10.1007%2fs13346-018-00596-w&partnerID=40&md5=87bd281b490efeb6588739abc50ef57c
The aim of this study was to employ experimental and molecular modelling approaches to use molecular level interactions to rationalise the selection of suitable polymers for use in the production of stable domperidone (DOMP) nanocrystals with enhanced bioavailability. A low-energy antisolvent precipitation method was used for the preparation and screening of polymers for stable nanocrystals of DOMP. Ethyl cellulose was found to be very efficient in producing stable DOMP nanocrystals with particle size of 130 ± 3 nm. Moreover, the combination of hydroxypropyl methylcellulose and polyvinyl alcohol was also shown to be better in producing DOMP nanocrystals with smaller particle size (200 ± 3.5 nm). DOMP nanosuspension stored at 2–8 °C and at room temperature (25 °C) exhibited better stability compared to the samples stored at 40 °C. Crystallinity of the unprocessed and processed DOMP was monitored by differential scanning calorimetry and powder X-ray diffraction. DOMP nanocrystals gave enhanced dissolution rate compared to the unprocessed drug substance. DOMP nanocrystals at a dose of 10 mg/kg in rats showed enhanced bioavailability compared to the raw drug substance and marketed formulation. A significant increase in plasma concentration of 2.6 μg/mL with a significant decrease in time (1 h) to reach maximum plasma concentration was observed for DOMP nanocrystals compared to the raw DOMP. Molecular modelling studies provided underpinning knowledge at the molecular level of the DOMP-polymer nanocrystal interactions and substantiated the experimental studies. This included an understanding of the impact of polymers on the size of nanocrystals and their associated stability characteristics. © 2018, Controlled Release Society.
Springer Verlag
2190393X
English
Article
All Open Access; Bronze Open Access
author Ndlovu S.T.; Ullah N.; Khan S.; Ramharack P.; Soliman M.; de Matas M.; Shahid M.; Sohail M.; Imran M.; Shah S.W.A.; Hussain Z.
spellingShingle Ndlovu S.T.; Ullah N.; Khan S.; Ramharack P.; Soliman M.; de Matas M.; Shahid M.; Sohail M.; Imran M.; Shah S.W.A.; Hussain Z.
Domperidone nanocrystals with boosted oral bioavailability: fabrication, evaluation and molecular insight into the polymer-domperidone nanocrystal interaction
author_facet Ndlovu S.T.; Ullah N.; Khan S.; Ramharack P.; Soliman M.; de Matas M.; Shahid M.; Sohail M.; Imran M.; Shah S.W.A.; Hussain Z.
author_sort Ndlovu S.T.; Ullah N.; Khan S.; Ramharack P.; Soliman M.; de Matas M.; Shahid M.; Sohail M.; Imran M.; Shah S.W.A.; Hussain Z.
title Domperidone nanocrystals with boosted oral bioavailability: fabrication, evaluation and molecular insight into the polymer-domperidone nanocrystal interaction
title_short Domperidone nanocrystals with boosted oral bioavailability: fabrication, evaluation and molecular insight into the polymer-domperidone nanocrystal interaction
title_full Domperidone nanocrystals with boosted oral bioavailability: fabrication, evaluation and molecular insight into the polymer-domperidone nanocrystal interaction
title_fullStr Domperidone nanocrystals with boosted oral bioavailability: fabrication, evaluation and molecular insight into the polymer-domperidone nanocrystal interaction
title_full_unstemmed Domperidone nanocrystals with boosted oral bioavailability: fabrication, evaluation and molecular insight into the polymer-domperidone nanocrystal interaction
title_sort Domperidone nanocrystals with boosted oral bioavailability: fabrication, evaluation and molecular insight into the polymer-domperidone nanocrystal interaction
publishDate 2019
container_title Drug Delivery and Translational Research
container_volume 9
container_issue 1
doi_str_mv 10.1007/s13346-018-00596-w
url https://www.scopus.com/inward/record.uri?eid=2-s2.0-85059829630&doi=10.1007%2fs13346-018-00596-w&partnerID=40&md5=87bd281b490efeb6588739abc50ef57c
description The aim of this study was to employ experimental and molecular modelling approaches to use molecular level interactions to rationalise the selection of suitable polymers for use in the production of stable domperidone (DOMP) nanocrystals with enhanced bioavailability. A low-energy antisolvent precipitation method was used for the preparation and screening of polymers for stable nanocrystals of DOMP. Ethyl cellulose was found to be very efficient in producing stable DOMP nanocrystals with particle size of 130 ± 3 nm. Moreover, the combination of hydroxypropyl methylcellulose and polyvinyl alcohol was also shown to be better in producing DOMP nanocrystals with smaller particle size (200 ± 3.5 nm). DOMP nanosuspension stored at 2–8 °C and at room temperature (25 °C) exhibited better stability compared to the samples stored at 40 °C. Crystallinity of the unprocessed and processed DOMP was monitored by differential scanning calorimetry and powder X-ray diffraction. DOMP nanocrystals gave enhanced dissolution rate compared to the unprocessed drug substance. DOMP nanocrystals at a dose of 10 mg/kg in rats showed enhanced bioavailability compared to the raw drug substance and marketed formulation. A significant increase in plasma concentration of 2.6 μg/mL with a significant decrease in time (1 h) to reach maximum plasma concentration was observed for DOMP nanocrystals compared to the raw DOMP. Molecular modelling studies provided underpinning knowledge at the molecular level of the DOMP-polymer nanocrystal interactions and substantiated the experimental studies. This included an understanding of the impact of polymers on the size of nanocrystals and their associated stability characteristics. © 2018, Controlled Release Society.
publisher Springer Verlag
issn 2190393X
language English
format Article
accesstype All Open Access; Bronze Open Access
record_format scopus
collection Scopus
_version_ 1820775468254625792